Profile
| Metric | Value |
|---|---|
| Full Name | ResMed Inc. |
| Ticker | NYSE: RMD |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Country | United States |
| IPO | |
| Indexes | |
| Website | resmed.co.in |
| Employees | 9,980 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $256.55 | |
| Price, 1D Change | +1.33% | |
| Market Cap | $37B | |
| TTM Dividend Yield | 0.88% | |
| PE Ratio | 26.25 | |
| Beta | 0.62 | |
| Revenue | $5B | |
| Revenue, 1Y Change | +9.84% | |
| EPS | $9.51 | |
| EPS, 1Y Change | +37.39% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.60 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $9.51 | |
| EPS Estimate | N/A | $10.91 |
| EPS Est. Change | N/A | +14.71% |
| Revenue | $5.15B | |
| Revenue Estimate | N/A | $5.60B |
| Revenue Est. Change | N/A | +8.85% |
| Current Price | $256.55 | |
| Price Target | - | $299.00 |
| Price Tgt. Change | - | +16.55% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $7.71 | $6.92 | -10.25% | |
| $9.50 | $9.51 | +0.06% | |
| $10.91 | N/A | +14.71% | |
| $12.03 | N/A | +26.53% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.68B | $4.69B | +0.13% | |
| $5.13B | $5.15B | +0.37% | |
| $5.60B | N/A | +8.85% | |
| $6.02B | N/A | +16.98% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +3.53% | |
| Price, 3Y | +9.29% | |
| Market Cap, 1Y | +2.91% | |
| Market Cap, 3Y | +8.60% | |
| Revenue, 1Y | +9.84% | |
| Revenue, 3Y | +43.83% | |
| EPS, 1Y | +37.39% | |
| EPS, 3Y | +79.35% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $256.55 | |
| SMA 200 | $256.14 | |
| SMA 200 vs Price | -0.16% | |
| SMA 50 | $249.76 | |
| SMA 50 vs Price | -2.65% | |
| Beta | 0.62 | |
| ATR | $5.47 | |
| 14-Day RSI | 52.56 | |
| 10-Day Volatility | 22.02% | |
| 1-Year Volatility | 26.06% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.60 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 0.83% | |
| Total Dividend | $2.12 | |
| Dividends Paid | $310.88M | |
| Payout Ratio | 22.19% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $5.15B | |
| EPS | $9.51 | |
| Gross Profit | $3.05B | |
| Gross Margin | 59.36% | |
| Operating Profit | $1.69B | |
| Operating Margin | 32.79% | |
| Net Income | $1.40B | |
| Net Margin | 27.22% | |
| EBITDA | $1.92B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.11 | |
| Current Ratio | 3.44 | |
| Quick Ratio | 2.53 | |
| - | ||
| F-Score | 7 | |
| Altman Z-Score | 12.90 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 26.25 | |
| PS Ratio | 7.12 | |
| PB Ratio | 6.12 | |
| EV/EBITDA | 18.43 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $5.97B | |
| Cash & Equivalents | $1.21B | |
| Total Assets | $8.17B | |
| Current Assets | $3.51B | |
| Total Liabilities | $2.21B | |
| Current Liabilities | $1.02B | |
| Total Debt | $851.81M | |
| Short Term Debt | $40.41M | |
| Accounts Payable | $278.16M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $3.46B | |
| Operating Expenses | $1.37B | |
| Cost Of Goods Sold | $2.09B | |
| SG&A | $991.02M | |
| D&A | $235.81M | |
| Interest Expense | $0.00 | |
| Income Tax | $276.84M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $1.75B | |
| CFI | -$200.05M | |
| CFF | -$606.25M | |
| Capex | $100.64M | |
| Free Cash Flow | $1.65B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Stifel | → | |
| Baird | → | |
| Baird | → | |
| RBC Capital | → | |
| Mizuho | → | |
| Keybanc | → | |
| Morgan Stanley | → | |
| Wells Fargo | ||
| Citigroup | ||
| UBS | → |
Analyst sentiment
Institutional ownership
Screeners with RMD
FAQ
What is the ticker symbol for ResMed Inc.?
The ticker symbol for ResMed Inc. is NYSE:RMD
Does ResMed Inc. pay dividends?
Yes, ResMed Inc. pays dividends. The last payment was $0.60, with an ex-dividend date on November 13, 2025
What sector is ResMed Inc. in?
ResMed Inc. is in the Healthcare sector
What industry is ResMed Inc. in?
ResMed Inc. is in the Medical Instruments & Supplies industry
What country is ResMed Inc. based in?
ResMed Inc. is headquartered in United States
When did ResMed Inc. go public?
ResMed Inc. initial public offering (IPO) was on June 2, 1995
Is ResMed Inc. in the S&P 500?
Yes, ResMed Inc. is included in the S&P 500 index
Is ResMed Inc. in the NASDAQ 100?
No, ResMed Inc. is not included in the NASDAQ 100 index
Is ResMed Inc. in the Dow Jones?
No, ResMed Inc. is not included in the Dow Jones index
When was ResMed Inc. last earnings report?
ResMed Inc.'s most recent earnings report was on October 30, 2025
When does ResMed Inc. report earnings?
The next expected earnings date for ResMed Inc. is January 29, 2026
Data Sources & References
- RMD Official Website www.resmed.co.in
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/943819/000094381925000090/0000943819-25-000090-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/943819/000094381925000035/0000943819-25-000035-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- RMD Profile on Yahoo Finance finance.yahoo.com/quote/RMD
- RMD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rmd